Get 20% lifetime commission for referring investors to digrin.com
here.
NRx Pharmaceuticals, Inc. (NRXP) Financials
NRXP Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 34.2 million | 34.3 million |
| March 31, 2026 | 11.9 million | 25.7 million |
| Dec. 31, 2025 | 13.0 million | 28.9 million |
| Sept. 30, 2025 | 15.0 million | 40.8 million |
NRXP Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -9.8 million | 139000 |
| March 31, 2026 | -4.3 million | 151000 |
| Dec. 31, 2025 | -3.7 million | 81000 |
| Sept. 30, 2025 | -2.9 million | 68000 |
NRXP Net Income
No data available :(
NRXP Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 26.7 million | - | 834000 |
| March 31, 2026 | 6.7 million | - | 934000 |
| Dec. 31, 2025 | 7.8 million | - | 315000 |
| Sept. 30, 2025 | 7.2 million | - | 347000 |
NRXP Shares Outstanding
NRXP Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 897000 | 2.1 million | 4.7 million | - |
| March 31, 2026 | - | 1.3 million | 3.7 million | - |
| Dec. 31, 2025 | - | 558000 | 4.5 million | - |
| Sept. 30, 2025 | - | 1.4 million | 2.8 million | - |
NRXP Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 1.1 million | 843000 |
| March 31, 2026 | 1.1 million | 796000 |
| Dec. 31, 2025 | 983000 | 508000 |
| Sept. 30, 2025 | 242000 | 138000 |
NRXP Revenue by Segment
Graph available only for paid members. Upgrade to see it.
NRXP
Price: $2.60
52 week price:
Earnings Per Share: -0.51 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 246900
Market Capitalization: 125.8 million